Jane Street Group, LLC Intra Cellular Therapies, Inc. Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$38.74 - $62.09 $127,842 - $204,897	-3,300 Reduced 8.53%	35,400 $2.17 Million
Q4 2021 Feb 15, 2022	BUY	$35.2 - $53.42 $1.12 Million - $1.7 Million	31,900 Added 469.12%	38,700 $2.03 Million
Q3 2021 Nov 16, 2021	SELL	$28.72 - $42.49 $347,512 - $514,129	-12,100 Reduced 64.02%	6,800 $254,000
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $131,850 - $200,250	4,500 Added 31.25%	18,900 $771,000
Q1 2021 May 18, 2021	SELL	$30.8 - $39.51 $1.03 Million - $1.32 Million	-33,400 Reduced 69.87%	14,400 $489,000
Q4 2020 Feb 17, 2021	SELL	$23.34 - $32.22 $1.21 Million - $1.68 Million	-52,000 Reduced 52.1%	47,800 $1.52 Million
Q3 2020 Nov 17, 2020	SELL	$17.61 - $31.86 $2.82 Million - $5.1 Million	-160,100 Reduced 61.6%	99,800 $2.56 Million
Q2 2020 Aug 17, 2020	BUY	$14.35 - $26.64 $3.5 Million - $6.5 Million	244,000 Added 1534.59%	259,900 $6.67 Million
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $1.66 Million - $4.47 Million	-135,100 Reduced 89.47%	15,900 $244,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $1.1 Million - $5.81 Million	151,000 New	151,000 $5.18 Million

402

89.5M

301K

277K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.64B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.